Skip to content
★ Sign in to follow
알테

알테오젠 Stock: price and insider trades · South Korea

KR·Mcap ₩14.7THealth Care

4 insiders bought €598.0M of shares over the last 90 days, the latest by 김항연, filed 13 Aug 2026.

Insider Decl.
36
Thresholds
n/a
Buy Volume
€937M
25 ops. · all time
Sell Volume
€6M
1 ops. · all time

Who traded when

BuySale
박순재1 buy1 sale
고인영1 buy
김항연1 buy
전태연1 buy

Analyst consensus: bullish or bearish?

Analysts rate 알테오젠 Buy (bullish), based on 6 analysts. Average price target: ₩405,513.

Fundamental score
Ranked 5,137 of 26,913 companies
67.5
score / 100
Value
40
Quality
95
FCF yld0.7%
Earn yld1.0%
EV/EBITDA·
ROE36%
Gross mgn77%
Net mgn66%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩211,500
Analyst consensus
6 analysts
Buy
₩310,000Target ₩405,513(+92%)₩520,000
Income statement
Revenue₩215.9B
Gross profit₩165.6B77% margin
EBITDA₩179.2B83% margin
Net income₩141.7B75.5% margin
Valuation
PER (forward)39.2x
Beta0.98
Balance sheet & cash
Market cap₩14.7T
Total debt₩7.1B
Free Cash Flow₩90.7B
Debt / Equity1%
Profitability & ownership
ROE35.6%
ROA11.2%
% insiders25.5%
% institutions18.2%
Last declaration on 13 August 2026
Declarations37 total
  • ▲
    사외이사Executives(filed)
    €2,924est.0DART
    15 sharesShareKRXDART:20260813001773
    Canonical exit: 11 Nov 2026 (T+90)
  • ▲
    이사회의장Executives(filed)
    €596.8Mest.0DART
    3,061,800 sharesShareKRXDART:20260813001689
    Canonical exit: 11 Nov 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €421kest.0DART
    2,160 sharesShareKRXDART:20260813001720
    Canonical exit: 11 Nov 2026 (T+90)
  • ▲
    CFOExecutives(filed)
    €760kest.0DART
    3,900 sharesShareKRXDART:20260813001753
    Canonical exit: 11 Nov 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • ▼
    Executives
    €6.2Mest.0DART
    30,500 sharesKRXDART:20260407003590
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €14.6Mest.0DART
    62,000 sharesKRXDART:20241121000172
    Canonical exit: 19 Feb 2025 (T+90)
  • ▲
    Executives
    €243.2Mest.0DART
    962,000 sharesKRXDART:20241030000276
    Canonical exit: 27 Jan 2025 (T+90)
  • ▲
    부사장Executives
    0DART
    ShareKRXDART:20230922000520
    Canonical exit: 17 Dec 2023 (T+90)
  • ▲
    Executives(filed)
    €32.7Mest.0DART
    962,000 sharesKRXDART:20230405003240
    Canonical exit: 4 Jul 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221110000226
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221110000246
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221110000234
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221110000215
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221110000256
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20221013000509
    Canonical exit: 11 Jan 2023 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    ShareKRXDART:20220906000327
    Canonical exit: 5 Dec 2022 (T+90)

25 of 37 declarations

About 알테오젠

Of the 36 filings for 알테오젠, 25 are purchases and only one is a sale, or 96% purchases among open-market trades, and none carries an amount. This South Korean Healthcare & Pharma company, listed on the Korean exchange, is valued at KRW 16,607.1 billion; its 7 filers hold 25.5%.

전태연, filed with the role 대표이사, made 18 filings, all purchases. 형인우 has 4, also all purchases, and 박순재 (이사회의장) has 2, one purchase and one sale. The company 알테오젠 itself appears on 8 filings of another kind.

Read moreShow less

On August 13, 2026, 4 filers filed on the same day. Between March 12, 2021 and August 13, 2026, the year 2021 counts 11 filings, 2022 has 10, 2023 has 6, 2024 has 3 and 2026 has 6. Over the last twelve months, 6 filings are published, 4 of them purchases and one a sale. The publication delay is a median of 3 days, but measured on only 4 filings.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations